Symbiotics as a preventive measure against ventilator-associated pneumonia

Critical Care Medicine

Volumn 38, Issue 6, 2010, Pages 1506-1507

  Schultz, Marcus J ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PREBIOTIC AGENT; PROBIOTIC AGENT;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; CLINICAL TRIAL; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; GRAM NEGATIVE BACTERIUM; HUMAN; INCIDENCE; LENGTH OF STAY; LETTER; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; STAPHYLOCOCCUS AUREUS; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 77953054532     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181d8c473     Document Type: Letter

References (6)

1. Siempos II, Ntaidou TK, Falagas ME: Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials. Crit Care Med 2010: 38:954-962
2. Marshall JC: Gastrointestinal flora and its alterations in critical illness. Curr Opin Clin Nutr Metab Care 1999; 2:405-411
3. du Moulin GC, Paterson DG, Hedley-Whyte J, et al: Aspiration of gastric bacteria in antacidtreated patients: A frequent cause of postoperative colonisation of the airway. Lancet 1982; 1:242-245
4. Schultz MJ, de Jonge E, Kesecioglu J: Selective decontamination of the digestive tract reduces mortality in critically ill patients. Crit Care 2003; 7:107-110
5. de Jonge E, Schultz MJ, Spanjaard L, et al: Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: A randomised controlled trial. Lancet 2003; 362: 1011-1016
6. de Smet AM, Kluytmans JA, Cooper BS, et al: Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med 2009; 360:20-31